This study is testing whether adding a personalized cancer vaccine called EVX-01 to a standard immunotherapy drug (pembrolizumab) can better control advanced melanoma that cannot be surgically removed. It involves about 17 adults with stage III or IV melanoma who have not yet rec…
Phase: PHASE2 • Sponsor: Evaxion Biotech A/S • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC